Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Полное описание

Библиографические подробности

Главные авторы:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2006-04-01
Серии:	AIDS Research and Therapy
Online-ссылка:	http://www.aidsrestherapy.com/content/3/1/11
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!